您的位置: 首页 > 农业专利 > 详情页

Optimizing mifepristone levels for cushing's patients
专利权人:
Inc.;Corcept Therapeutics
发明人:
Joseph Belanoff,Coleman Gross
申请号:
US15133791
公开号:
US09943526B2
申请日:
2016.04.20
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present invention provides a method for optimizing levels of mifepristone in a patient suffering from Cushing's syndrome. The method comprises the steps of treating the patient with seven or more daily doses of mifepristone over a period of seven or more days; testing the serum levels of the patient to determine whether the blood levels of mifepristone are greater than 1631 ng/mL; and adjusting the daily dose of the patient to achieve mifepristone blood levels greater than 1631 ng/mL.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充